HBCM
AQST icon

Heron Bay Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Heron Bay Capital Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,025
Closed -$21.5K – 94
2023
Q3 		$21.5K Buy
+14,025
New +$24.1K 0.01% 96

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Heron Bay Capital Management's AQST Position: Q4 2023 in Review

Heron Bay Capital Management sold out of Aquestive Therapeutics (AQST) in Q4 2023, closing a stake of 14,025 shares — an estimated $21.5K sold.

Heron Bay Capital Management first reported a position in AQST in Q3 2023 and held it in 1 quarter. The position peaked at $21.5K in Q3 2023. 57 funds tracked by Wall St. Rank hold AQST as of Q4 2023.

  • Heron Bay Capital Management reported no remaining Aquestive Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Heron Bay Capital Management sold 14,025 Aquestive Therapeutics shares in Q4 2023, an estimated $21.5K.
  • Heron Bay Capital Management first reported a position in Aquestive Therapeutics in Q3 2023 and held it in 1 quarter.
  • Heron Bay Capital Management's Aquestive Therapeutics position peaked at $21.5K in Q3 2023.
  • 57 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2023.

Based on Heron Bay Capital Management's 13F filing for Q4 2023, filed 12 Jan 2024.